Fetal hemoglobin in sickle cell anemia: Determinants of response to hydroxyurea

Blood

Volumn 89, Issue 3, 1997, Pages 1078-1088

  Steinberg, Martin H ^a   Lu, Zhi Hong ^b   Barton, Franca B ^b   Terrin, Michael L ^b   Charache, Samuel ^b   Dover, George J ^b  

^a VETERANS AFFAIRS MEDICAL CENTER   (United States)

^b NONE

Author keywords

[No Author keywords available]

Indexed keywords

HEMOGLOBIN F; HYDROXYUREA;

ADULT; ARTICLE; BONE MARROW SUPPRESSION; CLINICAL TRIAL; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; DOUBLE BLIND PROCEDURE; FEMALE; GENETIC VARIABILITY; HAPLOTYPE; HUMAN; HUMAN CELL; LEUKOCYTE COUNT; MAJOR CLINICAL STUDY; MALE; MULTICENTER STUDY; PHENOTYPE; PRIORITY JOURNAL; RANDOMIZED CONTROLLED TRIAL; RETICULOCYTE COUNT; SICKLE CELL ANEMIA; SICKLE CELL CRISIS;

EID: 0030893396     PISSN: 00064971     EISSN: None     Source Type: Journal    
DOI: 10.1182/blood.v89.3.1078     Document Type: Article

References (49)

1. Platt OS, Thorington BD, Brambilla DJ, Milner PF, Rosse WF, Vichinsky E, Kinney TR: Pain in sickle cell disease-rates and risk factors. N Engl J Med 325:11, 1991
2. Platt OS, Brambilla DJ, Rosse WF, Milner PF, Castro O, Steinberg MH, Klug PP: Mortality in sickle cell disease: Life expectancy and risk factors for early death. N Engl J Med 330:1639, 1994
3. Steinberg MH, Hsu H, Nagel RL, Milner PF, Adams JG, Benjamin L, Fryd S, Gillette P, Gilman J, Josifovska O, Hellman-Erlingsson S, Safaya S, Huey L, Rieder RF: Gender and haplotype effects upon hematological manifestations of adult sickle cell anemia. Am J Hematol 48:175, 1995
4. Charache S, Dover GJ, Moore RD, Eckert S, Ballas SK, Koshy M, Milner PFA, Orringer EP, Phillips G, Jr., Platt OS, Thomas GH: Hydroxyurea: Effects on hemoglobin F production in patients with sickle cell anemia. Blood 79:2555, 1992
5. Rodgers GP, Dover GJ, Noguchi CT, Schechter AN, Nienhuis AW: Hematologie responses of patients with sickle cell disease to treatment with hydroxyurea. N Engl J Med 322:1037, 1990
6. Charache S, Terrin ML, Moore RD, Dover GJ, Barton FB, Eckert SV, McMahon RP, Bonds DR, Multicenter Study of Hydroxyurea in Sickle Cell Anemia: Effect of hydroxyurea on the frequency of painful crises in sickle cell anemia. N Engl J Med 332:1317, 1995
7. Nagel RL, Fabry ME, Pagnier J, Zohoun I, Wajcman H, Baudin V, Labie D: Hematologically and genetically distinct forms of sickle cell anemia in Africa. The Senegal type and the Benin type. N Engl J Med 312:880, 1984
8. Gγ globin production. Blood 66:783, 1985
9. Blau CA, Stamatoyannopoulos G: Regulation of fetal hemoglobin, in Embury SH, Hebbel RP, Mohandas N, Steinberg MH (eds): Sickle Cell Disease: Basic Principles and Clinical Practice. New York, NY, Raven, 1994, p 247
10. Thein SL, Sampietro M, Rohde K, Rochette J, Weatherall DJ, Lathrop GM, Demenais F: Detection of a major gene for heterocellular hereditary persistence of fetal hemoglobin after accounting for genetic modifiers. Am J Hum Genet 54:214, 1994
11. Chang YC, Smith KD, Serjeant G, Dover G: The X-linked F cell production locus: Genetic mapping and role in fetal hemoglobin production. Clin Res 42:237A, 1994 (abstr)
12. Miyoshi K, Kaneto Y, Kawai H, Ohchi H, Niki S, Hasegawa K, Shirakami A, Yamano T: X-linked dominant control of F-cells in normal adult life: Characterization of the Swiss type as hereditary persistence of fetal hemoglobin regulated dominantly by gene(s) on X chromosome. Blood 72:1854, 1988
13. Dover GJ, Smith KD, Chang YC, Purvis S, Mays A, Meyers DA, Sheils C, Serjeant G: Fetal hemoglobin levels in sickle cell disease and normal individuals are partially controlled by an X-linked gene located at Xp22.2. Blood 80:816, 1992
14. Chang YC, Smith KD, Moore RD, Serjeant GR, Dover GJ: An analysis of fetal hemoglobin variation in sickle cell disease: The relative contributions of the X-linked factor, β-globin haplotypes, α-globin gene number, gender, and age. Blood 85:1111, 1995
15. Ware RE, Steinberg MH, Kinney TR: Hydroxyurea: An alternative to transfusion therapy for stroke in sickle cell anemia. Am J Hematol 50:140, 1995
16. Charache S, Dover GJ, Moyer MA, Moore JW: Hydroxyurea-induced augmentation of fetal hemoglobin production in patients with sickle cell anemia. Blood 69:109, 1987
17. Charache S, Terrin ML, Moore RD, Dover GJ, McMahon RP, Barton FB, Waclawiw M, Eckert SV: Design of the multicenter study of hydroxyurea in sickle cell anemia. Control Clin Trials 16:432, 1995
18. Baysal E, Carver MFH: The β-and δ-thalassemia repository (eighth edition). Hemoglobin 19:213, 1995
19. Metzger DK, Charache S: Flow cytometric reticulocyte counting with thioflavin T in a clinical hematology laboratory. Arch Pathol Lab Med 111:540, 1987
20. Blin N, Stafford DW: A general method for isolation of high molecular weight DNA from eukaryotes. Nucleic Acids Res 3:2303, 1976
21. Steinberg MH, Coleman MB, Adams JG, Hartmann RC, Saba H, Anagnou NP: A new gene deletion in the alpha-like globin gene cluster as the molecular basis for the rare alpha-thalassemia-1(-/ αα) in blacks: HbH disease in sickle cell trait. Blood 67:469, 1986
22. Chehab FF, Doherty M, Cai S, Kan YW, Cooper S, Rubin EM: Detection of sickle cell anaemia and thalassaemias. Nature 329:293, 1987
23. Betke K, Marti HR, Schlicht I: Estimation of small percentages of foetal haemoglobin. Nature 184:1887, 1959
24. Dover GJ, Boyer SH: Fetal hemoglobin-containing cells have the same mean corpuscular hemoglobin as cells without fetal hemoglobin: A reciprocal relationship between γ-and-β-globin gene expression in normal subjects and those with high fetal hemoglobin production. Blood 69:1109, 1987
25. Dover GJ, Boyer SH, Bell WR: Microscopic method for assaying F cell production: Illustrative changes during infancy and in aplastic anemia. Blood 52:664, 1978
26. Dover GJ, Boyer SH, Charache S, Heintzelman K: Individual variation in the production and survival of F cells in sickle-cell disease. N Engl J Med 299:1428, 1978
27. Fabricius E, Rajewsky MF: Determination of hydroxyurea in mammalian tissues und blood. Rev Eur Etudes Clin Biol 16:679, 1971
28. Fineberg SE: The Analysis of Cross-classified Categorical Data. Cambridge, MA, MIT Press, 1980
29. Draper NR, Smith H: Applied Regression Analysis. New York, NY, Wiley, 1966
30. Liang KY, Zeger SL: Longitudinal data analysis using generalized linear models. Biometrika 73:13, 1986
31. Higgs DR, Aldridge BE, Lamb J, Clegg JB, Weatherall DJ, Hayes RJ, Grandison Y, Lowrie Y, Mason KP, Serjeant BE, Serjeant GR: The interaction of alpha-thalassemia and homozygous sickle-cell disease. N Engl J Med 306:1441, 1982
32. Steinberg MH, Rosenstock W, Coleman MB, Adams JG, III, Platica O, Cedeno M, Reider RF, Wilson JT, Milner P, West S: Effects of thalassemia and microcytosis upon the hematological and vaso-occlusive severity of sickle cell anemia. Blood 63:1353, 1984
33. Schroeder WA, Powars DR, Kay LM, Chan LS, Huynh V, Shelton JB, Shelton JR: β-Cluster haplotypes α-gene status and hematological data from SS SC and S-β-thalassemia patients in southern California. Hemoglobin 13:325, 1989
34. Charache S, Barton FB, Moore RD, Terrin ML, Steinberg MH, Dover GJ, Ballas SK, McMahon RP, Castro O: Fetal hemoglobin, hydroxyurea, and sickle cell anemia: Clinical utility of a hemoglobin "switching" agent. Medicine 75:1, 1996
35. Orkin SH, Kazazian HH Jr, Antonarakis SE, Goff SC, Boehm CD, Sexton JP, Waber PG, Giardina PJ: Linkage of beta-thalassaemia mutations and beta-globin gene polymorphisms with DNA polymorphisms in human beta-globin gene cluster. Nature 296:627, 1982
36. Antonarakis SE, Boehm CD, Giardina PV, Kazazian HH: Nonrandom association of polymorphic restriction sites in the β-globin gene cluster. Proc Natl Acad Sci USA 79:137, 1982
37. Pagnier J, Mears JG, Dunda-Belkhodja O, Schaefer-Rego KE, Beldjord C, Nagel RL, Labie D: Evidence for the multicentric origin of the sickle cell hemoglobin gene in Africa. Proc Natl Acad Sci USA 81:1771, 1984
38. S Gene-cluster haplotypes in sickle cell anemia: Clinical and hematologie features. Hematol Oncol Clin North Am 5:475, 1991
39. S-Gene-cluster haplotypes as prognostic indicators of vital organ failure. Semin Hematol 28:202, 1991
40. S gene cluster haplotypes as genetic markers for severe disease expression. Am J Dis Child 147:1197, 1993
41. Powars DR, Elliott Mills DD, Chan L: Chronic renal failure in sickle cell disease: Risk factors, clinical course, and mortality. Ann Intern Med 115:614, 1991
42. Hayes RJ, Beckford M, Grandison Y, Mason K, Serjeant BE, Serjeant GR: The haematology of steady state homozygous sickle cell disease: Frequency distributions variation with age and sex, longitudinal observations. Br J Haematol 59:369, 1985
43. West MS, Wethers D, Smith J, Steinberg MH, Coop Study of Sickle Cell Diseuse: Laboratory profile of sickle cell disease: A cross-sectional analysis. J Clin Epidemiol 45:893, 1992
44. Bridges K, Barabino G, Brugnara C, Cristoph G, Cho M, Dover G, Eaton W, Ewenstein B, Golan D, Guttman C, Hofrichter J, Mulkem R, Zhang B: Hydroxyurea changes SS RBC biochemical/biophysical profile to that of SC RBCs. Blood 84:413a, 1994
45. Orringer EP, Blythe DSB, Johnson AE, Phillips G, Jr., Dover GJ, Parker JC: Effects of hydroxyurea on hemoglobin F and water content in the red blood cells of dogs and of patients with sickle cell anemia. Blood 78:212, 1991
46. Adragna NC, Fonseca P, Lauf PK: Hydroxyurea affects cell morphology cation transport and red blood cell adhesion in cultured vascular endothelial cells. Blood 83:553, 1994
47. Steinberg MH, Nagel RL, Brugnara C: Hydroxyurea independent of HbF alters the erythrocytes of Hb SC disease. J Invest Med 44:233A, 1996
48. Dover GJ, Humphries RK, Moore JG, Ley TJ, Young NS, Charache S, Nienhuis AW: Hydroxyurea induction of hemoglobin F production in sickle cell disease: Relationship between cytotoxicity and F cell production. Blood 67:735, 1986
49. Rodgers GP, Dover GJ, Uyesaka N, Noguchi CT, Schechter AN, Nienhuis AW: Augmentation by erythropoietin of the fetalhemoglobin response to hydroxyurea in sickle cell disease. N Engl J Med 338:73, 1993